MoonLake Immunotherapeutics (MLTX)
Earnings
Annual and quarterly EPS data presented alongside analyst estimates, earnings surprises, and historical growth statistics. The side-by-side view of reported versus estimated EPS — combined with surprise percentage and report timing — allows investors to assess whether a company consistently beats, meets, or misses market expectations, and how that track record has evolved across full economic cycles.
Earnings annual
Fiscal date endingReported EPS
Dec 31, 2020
-0.01
Dec 31, 2021
-0.31
Dec 31, 2022
-1.39
Dec 31, 2023
-0.76
Dec 31, 2024
-1.89
Dec 31, 2025
-3.52
Mar 31, 2026
-0.98
Jun 30, 2026
-1.82
Calculation
Growth rate
-110.31%
Average
-1.335
Maximum
Dec 31, 2020
-0.01
Minimum
Dec 31, 2025
-3.52
Median
Dec 31, 2022
-1.39
Earnings quarterly
| Fiscal date ending | Sep 30, 2020 |
| Reported date | Dec 3, 2020 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Dec 31, 2020 |
| Reported date | Mar 31, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.01 |
| Estimated EPS | |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2021 |
| Reported date | May 21, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.01 |
| Estimated EPS | |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2021 |
| Reported date | Aug 16, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.01 |
| Estimated EPS | |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Sep 30, 2021 |
| Reported date | Nov 12, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.14 |
| Estimated EPS | |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Dec 31, 2021 |
| Reported date | Feb 17, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.15 |
| Estimated EPS | |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2022 |
| Reported date | May 16, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.35 |
| Estimated EPS | -0.35 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Jun 30, 2022 |
| Reported date | Aug 12, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.34 |
| Estimated EPS | -0.54 |
| Surprise | 0.2 |
| Surprise (%) | 37.037% |
| Fiscal date ending | Sep 30, 2022 |
| Reported date | Nov 14, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | -0.27 |
| Estimated EPS | -0.34 |
| Surprise | 0.07 |
| Surprise (%) | 20.5882% |
| Fiscal date ending | Dec 31, 2022 |
| Reported date | Mar 20, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.43 |
| Estimated EPS | -0.28 |
| Surprise | -0.15 |
| Surprise (%) | -53.5714% |
| Fiscal date ending | Mar 31, 2023 |
| Reported date | May 11, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.23 |
| Estimated EPS | -0.31 |
| Surprise | 0.08 |
| Surprise (%) | 25.8065% |
| Fiscal date ending | Jun 30, 2023 |
| Reported date | Aug 10, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.23 |
| Estimated EPS | -0.29 |
| Surprise | 0.06 |
| Surprise (%) | 20.6897% |
| Fiscal date ending | Sep 30, 2023 |
| Reported date | Nov 14, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.18 |
| Estimated EPS | -0.25 |
| Surprise | 0.07 |
| Surprise (%) | 28% |
| Fiscal date ending | Dec 31, 2023 |
| Reported date | Feb 29, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.12 |
| Estimated EPS | -0.23 |
| Surprise | 0.11 |
| Surprise (%) | 47.8261% |
| Fiscal date ending | Mar 31, 2024 |
| Reported date | May 7, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.22 |
| Estimated EPS | -0.21 |
| Surprise | -0.01 |
| Surprise (%) | -4.7619% |
| Fiscal date ending | Jun 30, 2024 |
| Reported date | Aug 7, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.39 |
| Estimated EPS | -0.28 |
| Surprise | -0.11 |
| Surprise (%) | -39.2857% |
| Fiscal date ending | Sep 30, 2024 |
| Reported date | Nov 7, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.56 |
| Estimated EPS | -0.45 |
| Surprise | -0.11 |
| Surprise (%) | -24.4444% |
| Fiscal date ending | Dec 31, 2024 |
| Reported date | Feb 26, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.72 |
| Estimated EPS | -0.59 |
| Surprise | -0.13 |
| Surprise (%) | -22.0339% |
| Fiscal date ending | Mar 31, 2025 |
| Reported date | May 12, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.63 |
| Estimated EPS | -0.7355 |
| Surprise | 0.1055 |
| Surprise (%) | 14.344% |
| Fiscal date ending | Jun 30, 2025 |
| Reported date | Aug 5, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.87 |
| Estimated EPS | -0.76 |
| Surprise | -0.11 |
| Surprise (%) | -14.4737% |
| Fiscal date ending | Sep 30, 2025 |
| Reported date | Nov 5, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -1.1 |
| Estimated EPS | -0.89 |
| Surprise | -0.21 |
| Surprise (%) | -23.5955% |
| Fiscal date ending | Dec 31, 2025 |
| Reported date | Feb 25, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.92 |
| Estimated EPS | -0.9792 |
| Surprise | 0.0592 |
| Surprise (%) | 6.0458% |
| Fiscal date ending | Mar 31, 2026 |
| Reported date | May 11, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.98 |
| Estimated EPS | -0.92 |
| Surprise | -0.06 |
| Surprise (%) | -6.5217% |
| Fiscal date ending | Jun 30, 2026 |
| Reported date | Aug 10, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.84 |
| Estimated EPS | -0.9 |
| Surprise | 0.06 |
| Surprise (%) | 6.6667% |
Calculation
Growth rate
-∞%
Average
-0.404
Maximum
Sep 30, 2020
0
Minimum
Sep 30, 2025
-1.1
Median
Jun 30, 2022
-0.34